J&J considers potential sale or spinoff of Ortho Clinical Diagnostics

01/23/2013 | Reuters

Johnson & Johnson said it is exploring a possible sale or spinoff of its Ortho Clinical Diagnostics unit, which develops laboratory and blood transfusion testing tools. The company made the disclosure after reporting better-than-expected quarterly profits, driven by strong sales of its artificial hip and knee implants.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Actuary
Meridian Health Plan
Detroit, MI
Vice President of Finance
Urban Health Plan, Inc.
Bronx, NY
Director of Payor/Provider Contracting
U.S. Medical Management
Tryo, MI